A Cox regression analysis revealed that high TROP2 expression was not associated with lung cancer-specific (univariable analysis, P = 0.59 and multivariable analysis, P = 0.56) or overall survival (univariable analysis, P = 0.35 and multivariable analysis, P = 0.35) (Table 2). Here, TACSTD2 is linked to lung cancer.